PLYMOUTH, Minn., May 27 /PRNewswire/ -- ev3 Inc. today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Tuesday, June 10, 2008 at 11:00 a.m. PT (2:00 p.m. ET and 1:00 p.m. CT). The Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference will be held at the Ritz-Carlton Laguna Niguel in Dana Point, California.
To access the webcast, go to the investors’ section of the ev3 Web site at www.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to improving the lives of patients with vascular disease through the development of innovative endovascular therapies. ev3’s products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.
CONTACT: INVESTORS and MEDIA: Julie Tracy, Sr. Vice President, Chief
Communications Officer of ev3 Inc., +1-949-680-1375, jtracy@ev3.net
Web site: http://www.ev3.net//
